Skip to main content
. 2016 Aug 4;7(35):56699–56712. doi: 10.18632/oncotarget.11057

Figure 6. YAP/TAZ levels in liver metastases are highly correlated with Ki-67 and tumor relapse in colon cancer patients.

Figure 6

(A) Comparisons between the transcript levels of Ki-67, CTGF, Cyr61 and the AXL median transcript levels in the two liver metastases subgroups, ie YAP/TAZ low and YAP/TAZ high (description in Supplementary Material and Methods). (B) Kaplan-Meier survival analysis of colon cancer patients with liver metastases, according to the combined expression of YAP/TAZ transcripts. (C) Ki-67 and YAP/TAZ immunohistochemistry in liver metastases and analysis of the correlation between the percentages of Ki67 immunoreactive cells and nuclear YAP/TAZ staining (magnification × 100).